In a study of older postmenopausal women with type 2 diabetes (T2D), researchers explored pyridoxamine, a vitamin B6 metabolite, as a potential treatment for improving bone health. Pyridoxamine targets advanced glycation … [Read More]
A study found that certain medications, like GLP-1 receptor agonists (GLP-1 RAs) and fenofibrates (a medicine that can lower the level of cholesterol in the blood), can lower the risk … [Read More]
Artificial intelligence (AI) is a technology that mimics human intelligence to solve complex problems. In diabetes care, AI is increasingly used to manage complications such as hypoglycemia … [Read More]
Digital twins are advanced computer programs that simulate a real person using detailed data, such as genetics, cancer type, and treatment history. These virtual copies can predict disease progression, test treatments, and help … [Read More]
Artificial intelligence-assisted colonoscopy (AIAC) can improve the early detection of pre-cancerous lesions such as adenomas. However, studies reveal that AIAC also increases the chance of removing benign lesions—growths that pose … [Read More]
Automated insulin delivery (AID) systems have become increasingly vital in managing type 1 diabetes, not only improving glycemic control but also enhancing various aspects of patients’ quality of life. This review analyzed a great deal of … [Read More]
At a recent research meeting in Europe, researchers introduced a voice analysis AI model that aligns closely with the American Diabetes Association’s (ADA) risk test for detecting type 2 diabetes (T2D). … [Read More]
Phototherapy, or light therapy, is a treatment method that uses various types of light to address a range of medical conditions. It has been gaining attention for its effectiveness in treating skin disorders, mood disorders, and promoting … [Read More]
Alzheimer’s Disease is the commonest cause of dementia, and sadly, the number of people developing it continues to rise. A new study has introduced a promising blood test that can detect early signs … [Read More]
At the American Diabetes Association (ADA) Scientific Sessions, researchers presented new data using genetic testing to test for a trait called abnormal postprandial satiety (APS), or a “hungry gut.” Being able to … [Read More]